Home - Gastroenterology Advisor
WEBGI and Liver Disease in Pregnancy: AGA Clinical Practice Updates. By Colby Stong. The American Gastroenterological Association has released new guidance on the clinical management of pregnancy-related gastrointestinal and liver disease.
SGLT-2 Inhibitor Use Linked to Lower Parkinson Disease Risk in T2D
WEB5 hours ago · September 30, 2024. Compared with DPP-4 inhibitors, SGLT-2 inhibitors were linked to a lower risk for incidental Parkinson disease among older adults with type 2 diabetes. Use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors is associated with a significantly lower risk of developing Parkinson disease than dipeptidyl peptidase-4 …
FDA Alert: Gastroenterology Drug Approvals and New Indications
WEB3 days ago · FDA New Indications. Voquezna® (vonoprazan): Heartburn Associated With Nonerosive GERD. On July 18, 2024, the FDA approved vonoprazan for the relief of heartburn associated with nonerosive GERD in adults. 5. Medication Class: potassium-competitive acid blocker 6. Dosing: Relief of heartburn with nonerosive GERD in adults: 10 mg once daily for ...
Linaclotide Plus 3-L PEG Effective for Bowel Preparation in ...
WEB5 hours ago · September 30, 2024. Linaclotide consumed in combination with 3-L PEG is an effective method for bowel preparation prior to colonoscopy for those constipated. Among patients with constipation, 3-L polyethylene glycol (PEG) combined with a split dose of linaclotide for precolonoscopy preparation is superior to …
Colonic Diverticulitis: A Clinical Practice Update From the AGA
WEBJanuary 18, 2021. The American Gastroenterological Association (AGA) has developed a clinical practice update for managing patients with colonic diverticulitis. This guidance has been published in Gastroenterology. The update includes 14 best practices that are based on a review of meta-analyses, randomized controlled trials, observational ...
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Tradipitant Relieves Nausea, Other Gastroparesis Symptoms
WEBOct 27, 2022 · Tradipitant is efficacious for relieving nausea and other gastroparesis symptoms. Tradipitant significantly improved nausea and other symptoms in patients with idiopathic and diabetic gastroparesis compared with placebo, according to study results presented at the American College of Gastroenterology (ACG) 2022 Annual Meeting, held from October ...
Acute Pancreatitis Management: Guidelines From the American …
WEBApril 26, 2024. The American College of Gastroenterology (ACG) has released guidelines about the management of acute pancreatitis (AP) in The American Journal of Gastroenterology. In the United States, AP accounts for more than 1 million patient days in the hospital and more than $2.5 billion in health care costs.
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
WEBOct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually.